NCT05097534

Brief Summary

To improve diabetes self-management outcomes, patients with type 2 diabetes (n=150 - aged 13-84) recruited from St. Vincent Clinic (SVC) and Teen Health Center Inc., Clinics will be randomized using block randomization to receive standard of care or the integrated model. Patients in the intervention arm will be assessed for social and physical needs before being enrolled in a year-long education program (iDSMES). Enrollees will receive dietary counseling, physical and occupational therapy, in addition to other mental, financial and social benefits counseling. The investigators will compare the intervention outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Dec 2021

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 28, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

December 7, 2021

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

January 15, 2026

Status Verified

December 1, 2025

Enrollment Period

3.9 years

First QC Date

September 22, 2021

Last Update Submit

January 13, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline HbA1c

    measurement of hemoglobin A1c (HbA1c %)

    at 6 months

  • Change from baseline HbA1c

    measurement of hemoglobin A1c (HbA1c %)

    at 12 months

Secondary Outcomes (32)

  • Change from baseline weight

    at 6 months

  • Change from baseline weight

    at 12 months

  • Change from baseline blood pressure

    at 6 months

  • Change from baseline blood pressure

    at 12 months

  • Change from baseline lipid profile

    at 6 months

  • +27 more secondary outcomes

Study Arms (2)

iDSMES

ACTIVE COMPARATOR

Eligible study subjects randomized to the intervention arm will receive: A. Intensive Diabetes Self-Management, Education, and Support (iDSMES). Participants will be enrolled in groups in a virtual or in-person setting with their lifestyle coach, in this one-year educational program B. Services addressing Social Determinants of Health All study subjects will have their data collected at time points around baseline, 6 months and 12 months from consenting including glycemic control, hypertension management, dyslipidemia management, prevention or management of complications, healthcare outcomes, lifestyle change outcomes, patient-centeredness outcomes, Secondary diabetes self-management behaviors, self-efficacy in managing diabetes, diabetes distress, and Morisky Green Levine Medication Adherence Scale.

Other: iDSMES

Standard of Care

PLACEBO COMPARATOR

Eligible study subjects randomized to the intervention arm will receive standard of care offered to patients with diabetes.

Other: Standard of Care

Interventions

iDSMESOTHER

Intensive Diabetes Self-Management Education and Support combined with Addressing Social Determinants of Health

iDSMES

Standard of Care for patients with type 2 diabetes

Standard of Care

Eligibility Criteria

Age13 Years - 84 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 13-84, and
  • Patients diagnosed with type 2 diabetes, and
  • Patients have a BMI equal to or \>25 (23, if Asians), and
  • Hemoglobin A1c value equal to or \>7%

You may not qualify if:

  • Ages \<13 or \>84
  • Pregnancy. If a subject becomes pregnant, they will advised to discontinue the study.
  • Previous diagnosis of type 1 diabetes
  • Inability to participate for 12-month duration (e.g., Disorders that might compromise survival, planning to relocate outside the geographical coverage of University of Texas Medical Branch (UTMB) clinics
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Vincent House Clinic

Galveston, Texas, 77550, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2021

First Posted

October 28, 2021

Study Start

December 7, 2021

Primary Completion

October 31, 2025

Study Completion

October 31, 2025

Last Updated

January 15, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Locations